Welcome to the 10th CDD for Biologics Summit

Returning to Boston this fall at this opportune moment, the 10th anniversary of the CDD for Biologics Summit. This forum will unite 50+ decision-makers and industry experts from pharma and biotech to share their unfiltered lessons learned from validating and training computational models to streamline novel target validation, enhance biologics design, and empower developability predictions.

With brand new companies for 2025, including Lilly, Sanofi, GSK, Novartis, AstraZeneca, AI proteins, VRG Therapeutics & more, as well as real-world case studies with fresh data on de novo, generative AI and machine learning, this meeting is shaping up to be the best one yet.

Explore the case studies & full presentation details here: https://ter.li/yxz71y

🌟Here’s a glimpse of the key case studies showcased on the 2025 agenda:

Eli Lilly: Accelerate GPCR-targeted drug discovery by integrating visual screening with ligand-receptor interaction analysis
Jing Wang, Research Director of Structural and Computational Biology

Sanofi: Application of structural modeling to improve antigen-binding predictions in antibody and NANOBODY® design
Abhinav Gupta, Senior Scientist – AI Innovation for Antibody

VRG Therapeutics: Examining differences between structure-based & sequence-based de novo design across antigen diversity and design complexity
Gabor Oroszlan, In Silico and Platform Lead

AbbVie: Integrating predictive models to enhance biologics developability and accelerate design cycles
Mark Aquino, Principal Data Scientist II

Pre-Conference AI Validation Workshop with A-Alpha Bio, GSK, and Astellas: Building lab-in-the-loop validation systems and benchmarking generative AI outputs for biologics

View the program for 2025: https://ter.li/yxz71y

Want a breakdown of the event in numbers?

10th Annual Gathering of the CDD for Biologics Community
22 Expert Speakers from AstraZeneca, Sanofi, GSK, Novartis, AbbVie, Eli Lilly, Amgen, Takeda & more
50+ Senior Decision-Makers
6+ Hours of Dedicated Networking across Roundtables, Speed Networking & Informal Discussions
1 Interactive Poster Session Showcasing Innovative Research and Early-Stage Ideas

Join us there: https://ter.li/brn19c